Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Differentiated Thyroid Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT00794053
What this trial is testing

The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer

Who this might be right for
Thyroid CancerLymph Node Metastasis
University of Alexandria 45
Not applicableStudy completedNCT07115810
What this trial is testing

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

Who this might be right for
Differentiated Thyroid Cancer
King Faisal Specialist Hospital & Research Center 178
Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Not applicableUnknownNCT00749697
What this trial is testing

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Who this might be right for
Thyroid CarcinomaMetastatic Sites Lung Bone Nodal
Royal Marsden NHS Foundation Trust 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02152995
What this trial is testing

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+9 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT02731352
What this trial is testing

Study of Apatinib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04180007
What this trial is testing

Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

Who this might be right for
ThyroidMetastasisApatinib
Nanjing First Hospital, Nanjing Medical University 10
Not applicableEnded earlyNCT01403324
What this trial is testing

Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid CancerMetastases
Gustave Roussy, Cancer Campus, Grand Paris 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04171622
What this trial is testing

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8+3 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00104871
What this trial is testing

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+3 more
National Cancer Institute (NCI) 24
Not applicableActive Not RecruitingNCT03416686
What this trial is testing

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy

Who this might be right for
Differentiated Thyroid Cancer
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04061980
What this trial is testing

Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

Who this might be right for
BRAF NP_004324.2:p.V600MBRAF V600E Mutation PresentMetastatic Thyroid Gland Carcinoma+4 more
Providence Health & Services 24
Testing effectiveness (Phase 2)Study completedNCT01013597
What this trial is testing

Trial of LBH589 in Metastatic Thyroid Cancer

Who this might be right for
Thyroid Carcinoma
University of Wisconsin, Madison 13
Not applicableStudy completedNCT01534897
What this trial is testing

Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436

Who this might be right for
Papillary Thyroid Carcinoma
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)UnknownNCT05989425
What this trial is testing

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Fudan University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Novartis Pharmaceuticals 153
Not applicableUnknownNCT03845647
What this trial is testing

Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma.

Who this might be right for
Lymph Node DissectionLymph Node MetastasesDifferentiated Thyroid Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 50